Altered gut microbiome associated with overactive bladder and daily urinary urgency.
Teppei Okamoto, Shingo Hatakeyama, Atsushi Imai...
https://pubmed.ncbi.nlm.nih.gov/32419054/Actively Recruiting
Led by Aalborg University Hospital · Updated on 2026-04-17
110
Participants Needed
4
Research Sites
26 weeks
Total Duration
Researchers are investigating whether the bacterial communities in urine, perinealpreputial areas, and feces differ between children and adolescents aged 5 to 17 years who have Overactive Bladder OAB and Daytime Urinary Incontinence DUI compared to healthy peers without bladder symptoms. The study also aims to examine if these bacterial profiles vary with the severity of DUI and change during treatment. Additionally, a follow-up study will observe how the microbiota evolves with age and pubertal development in healthy children. The study includes three parts a cross-sectional comparison between children with OAB and DUI and healthy children, and two cohort follow-up studies monitoring changes in microbiota over time. Seventy children with OAB and DUI and forty healthy children will provide urine, perinealpreputial swabs, and fecal samples. Participants with OAB and DUI will be observed before and during new treatments, while healthy children will have follow-ups every six months until adulthood. Participants andor their parents will complete questionnaires, frequency and volume charts, and Dry Pies assessments. Samples will be collected at baseline and every six months for up to five years to track microbiota changes. Researchers will measure differences in urinary, perinealpreputial, and fecal microbiota at baseline, according to DUI severity, and during treatment. They will also study microbiota development related to age and puberty. Safety is monitored by urine dipstick tests and exclusion of infections or other conditions affecting results.
CONDITIONS
The Voided Urinary, Perineal, and Faecal Microbiota Among Children and Adolescents - the PpUF-study.
K
Kristina Thorsteinsson, MD
S
Søren Hagstrøm, MD, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Aalborg University Hospital
Lead Sponsor
Aarhus University Hospital
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - At baseline
Participants provide urine, perineal/preputial swabs, and fecal samples. Questionnaires and charts are completed to assess urinary symptoms and microbiota composition.
1 baseline visit (in-person)
Duration - Up to 5 years
Participants are followed over time to monitor changes in microbiota and urinary symptoms, including changes concurrent with treatment for daytime urinary incontinence or natural development in healthy children.
Follow-up visits every 6 months for up to 60 months
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Teppei Okamoto, Shingo Hatakeyama, Atsushi Imai...
https://pubmed.ncbi.nlm.nih.gov/32419054/Meghan M Pearce, Michael J Zilliox, Amy B Rosenfeld...
https://pubmed.ncbi.nlm.nih.gov/26210757/Paul F Austin, Stuart B Bauer, Wendy Bower...
https://pubmed.ncbi.nlm.nih.gov/25772695/Israel Franco
https://pubmed.ncbi.nlm.nih.gov/27530266/Dong Xing, Yi He Wang, Yi Bo Wen...
https://pubmed.ncbi.nlm.nih.gov/31804751/T C Warner, U Baandrup, R Jacobsen...
https://pubmed.ncbi.nlm.nih.gov/30930018/Lisa Karstens, Mark Asquith, Sean Davin...
https://pubmed.ncbi.nlm.nih.gov/27512653/Jae Min Chung, Sang Don Lee, Dong Il Kang...
https://pubmed.ncbi.nlm.nih.gov/18829077/Aalborg University Hospital
Lead Sponsor
Aarhus University Hospital
Collaborating Sponsor